Insights

Why Focus on Treating Diseases Instead of Curing Them?

It’s a tragic irony: So much money has been poured into treating diseases, but far less into actually curing them. The pharmaceutical...

Janssen reports positive topline results for Tremfya in Crohn’s at week 48

The IL-23 Pathway and Its Pivotal Role in Inflammatory Bowel Disease Research The incidence of inflammatory bowel disease (IBD),...

Surprising Things Your Walk Can Say About You

If you tend to veer to the left while walking, could be you’re anxious. And if you are an introvert, then you...

How Artificial Intelligence is Transforming the Healthcare Industry

Artificial Intelligence (AI) has positively impacted many industries including healthcare, transportation, e-commerce, and finance. According to a recent report, the global artificial...

The Changing Role of a Histotechnologist

Ask a doctor to describe a typical day’s work and her answer will likely sound significantly different than it would have a...

Addressing Unmet Need in Treatment-Resistant Cancers Through Purposeful R&D

Whenever I’m asked about what drives my passion for cancer treatment and oncology R&D, my answer is simple: with every innovation, we’re...

Patient-Centric Clinical Trials And The Role Of A Travel Concierge

Many people find booking plane tickets, arranging road transportation and overnight lodging overwhelming. Add into that mix the anxiety caused by serious...

Three ways Unified Communications Solutions are Changing the Pharmaceutical and Biotech Industries

If we’ve learned one thing during the COVID-19 pandemic. It’s that when faced with adversity. We can and will come up with...

Latest news

Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment

The deal involves a $16 million payment from Orion to Jemincare with milestones as well as royalty...
- Advertisement -

Several drug recalls hit the US market, including Pfizer’s Accupril

Leading pharmaceutical companies have been hit by recalls recently. These U.S. based drugs  include Jubilant’s Methylprednisolone ,...

Why Focus on Treating Diseases Instead of Curing Them?

It’s a tragic irony: So much money has been poured into treating diseases, but far less into...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

Empower Pharmacy inaugurates a $55m facility in Houston

A compounding pharmacy, which is also FDA...

Kintor and Fosun sign licensing agreement to market Covid-19 drug in India and 28 African nations

Kintor pharmaceutical has signed an agreement to authorize Shanghai Fosun Pharmaceutical Development to commercialize its drug,